Systemic gaps in antimicrobial resistance drive novel light-activated nanomaterial research amid unaddressed structural drivers of infection

Indigenous and traditional medical systems offer centuries of empirical knowledge on light-activated and plant-based antimicrobial strategies, yet these are systematically excluded from mainstream research agendas. For example, the use of copper in Ayurveda (*tamra*) for water storage aligns with modern findings on copper’s antimicrobial properties, yet such parallels are rarely explored in Western scientific literature. The dismissal of indigenous knowledge reflects a broader epistemic injustice that privileges lab-based innovation over community-validated practices. Integrating these systems could yield cost-effective, culturally resonant solutions to AMR.

The rise of AMR is historically tied to the mid-20th-century antibiotic revolution, which was rapidly co-opted by industrial agriculture and pharmaceutical capitalism. The 1950s saw the mass introduction of antibiotics in livestock farming, accelerating resistance while failing to address underlying sanitation and hygiene gaps. Colonial medical practices, such as forced vaccination campaigns in Africa and Asia, also contributed to the spread of resistant strains by disrupting local immune ecologies. Today’s focus on nanomaterials echoes past technological fixes (e.g., silver nanoparticles in the 19th century) that prioritized short-term gains over long-term ecological and social sustainability.

Cross-culturally, antimicrobial strategies vary from the use of sunlight and copper in South Asia to the reliance on honey and propolis in Middle Eastern and Mediterranean traditions. In sub-Saharan Africa, the Maasai use smoke from burning specific woods to sterilize milk containers, a practice with parallels to modern UV sterilization techniques. These diverse approaches highlight the need for a pluralistic, context-specific framework for AMR mitigation, rather than a one-size-fits-all technological solution. However, such comparisons are rarely made in Western scientific discourse, which often frames non-Western practices as 'alternative' rather than equally valid knowledge systems.

Scientifically, the research on light-activated nanomaterials (e.g., photocatalytic titanium dioxide) shows promise in disrupting bacterial cell membranes and viral envelopes under specific light wavelengths. However, the long-term ecological and health impacts of these materials—such as bioaccumulation in soil and water systems or unintended toxicity to human cells—remain understudied. The scientific community’s focus on lab-based efficacy often overlooks real-world deployment challenges, including the need for infrastructure to deliver light activation in clinical or agricultural settings. Additionally, the lack of standardized protocols for testing nanomaterial safety in diverse environments limits reproducibility and scalability.

Artistically and spiritually, light has long symbolized purity and healing across cultures, from the Hindu concept of *Agni* (fire god) to the Christian association of light with divine presence. In modern art, light-based installations (e.g., James Turrell’s work) explore the interplay between perception and healing, while indigenous ceremonies often use light (e.g., sun gazing) for spiritual and physical purification. These perspectives suggest that antimicrobial strategies rooted in light could be framed not just as technological interventions but as part of a holistic, culturally embedded approach to health. However, such dimensions are rarely integrated into scientific or policy discussions on AMR.

Future modelling of AMR must account for the unintended consequences of technological solutions, such as the potential for nanomaterials to drive further resistance or create new ecological imbalances. Scenario planning should prioritize prevention over cure, including investments in wastewater treatment, antibiotic stewardship in agriculture, and global surveillance systems for resistant strains. The rise of AI-driven drug discovery offers a parallel opportunity to model resistance patterns and design more sustainable antimicrobials, but this requires interdisciplinary collaboration beyond the current siloed approach. Without addressing structural drivers, even advanced nanomaterials will only delay the inevitable crisis of untreatable infections.

Marginalized communities—particularly in low-income countries and Indigenous populations—bear the brunt of AMR due to limited access to diagnostics, overcrowded living conditions, and reliance on counterfeit or substandard antibiotics. The global health community’s focus on high-tech solutions often ignores the lived experiences of those most affected, such as rural farmers in Southeast Asia or peri-urban slum dwellers in Africa. Additionally, the patenting of nanomaterials risks creating new forms of exclusion, where life-saving technologies become inaccessible to the very populations they aim to serve. Centering marginalized voices requires rethinking innovation as a public good, not a commodity.